INNATE PHARMA: ifrs:AdjustmentsForProvisions
| Value | {"amount": 839000.0} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | current |
| Entity | INNATE PHARMA |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-24T01:03:17.534690+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/b66f0c7a-e95f-4ca7-adce-8bf2858e9a58
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:9695002Y8420ZB8HJE29:2022-12-31Retrieved: 2026-08-24T01:03:17.534690+02:00
Raw response sha256:
53d82a9d3a67280755c68bee6873bd4d…Cite as: FACTANKER, https://factanker.com/fact/b66f0c7a-e95f-4ca7-adce-8bf2858e9a58
History
- no predecessors — first report